US slammed for targeting biotech firms

Beijing condemned on Tuesday the so-called Biosecure Act passed by the United States House of Representatives, urging Washington to stop unwarranted oppression against Chinese enterprises.

The bill, passed by 306 to 81 votes on Monday, would prohibit the US government from contracting with, or providing grants to, companies that do business with a "biotechnology company of concern".

It names five Chinese companies — BGI, MGI and its subsidiary Complete Genomics, WuXi AppTec, and WuXi Biologics.